Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Abstract Nonalcoholic fatty liver disease (NAFLD) occurs due to the accumulation of fat in the liver, leading to fatal liver diseases such as nonalcoholic steatohepatitis (NASH) and cirrhosis. Elucidation of the molecular mechanisms underlying NAFLD is critical for its prevention and therapy. Here,...

Full description

Bibliographic Details
Main Authors: Jung-Hwan Baek, Myung Sup Kim, Hye Ryeon Jung, Min-Seon Hwang, Chan-ho Lee, Dai Hoon Han, Yong-ho Lee, Eugene C. Yi, Seung-Soon Im, Ilseon Hwang, Kyungeun Kim, Joon-Yong Chung, Kyung-Hee Chun
Format: Article
Language:English
Published: Nature Publishing Group 2023-07-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-023-01036-7
_version_ 1826991213983563776
author Jung-Hwan Baek
Myung Sup Kim
Hye Ryeon Jung
Min-Seon Hwang
Chan-ho Lee
Dai Hoon Han
Yong-ho Lee
Eugene C. Yi
Seung-Soon Im
Ilseon Hwang
Kyungeun Kim
Joon-Yong Chung
Kyung-Hee Chun
author_facet Jung-Hwan Baek
Myung Sup Kim
Hye Ryeon Jung
Min-Seon Hwang
Chan-ho Lee
Dai Hoon Han
Yong-ho Lee
Eugene C. Yi
Seung-Soon Im
Ilseon Hwang
Kyungeun Kim
Joon-Yong Chung
Kyung-Hee Chun
author_sort Jung-Hwan Baek
collection DOAJ
description Abstract Nonalcoholic fatty liver disease (NAFLD) occurs due to the accumulation of fat in the liver, leading to fatal liver diseases such as nonalcoholic steatohepatitis (NASH) and cirrhosis. Elucidation of the molecular mechanisms underlying NAFLD is critical for its prevention and therapy. Here, we observed that deubiquitinase USP15 expression was upregulated in the livers of mice fed a high-fat diet (HFD) and liver biopsies of patients with NAFLD or NASH. USP15 interacts with lipid-accumulating proteins such as FABPs and perilipins to reduce ubiquitination and increase their protein stability. Furthermore, the severity of NAFLD induced by an HFD and NASH induced by a fructose/palmitate/cholesterol/trans-fat (FPC) diet was significantly ameliorated in hepatocyte-specific USP15 knockout mice. Thus, our findings reveal an unrecognized function of USP15 in the lipid accumulation of livers, which exacerbates NAFLD to NASH by overriding nutrients and inducing inflammation. Therefore, targeting USP15 can be used in the prevention and treatment of NAFLD and NASH.
first_indexed 2024-03-12T17:09:50Z
format Article
id doaj.art-fa3fd4008685464f806a79d36788d5e5
institution Directory Open Access Journal
issn 2092-6413
language English
last_indexed 2025-02-18T08:32:01Z
publishDate 2023-07-01
publisher Nature Publishing Group
record_format Article
series Experimental and Molecular Medicine
spelling doaj.art-fa3fd4008685464f806a79d36788d5e52024-11-03T12:11:20ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132023-07-015571520153010.1038/s12276-023-01036-7Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitisJung-Hwan Baek0Myung Sup Kim1Hye Ryeon Jung2Min-Seon Hwang3Chan-ho Lee4Dai Hoon Han5Yong-ho Lee6Eugene C. Yi7Seung-Soon Im8Ilseon Hwang9Kyungeun Kim10Joon-Yong Chung11Kyung-Hee Chun12Department of Biochemistry & Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of MedicineDepartment of Biochemistry & Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of MedicineDepartment of Molecular Medicine and Biopharmaceutical Sciences, School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National UniversityDepartment of Biochemistry & Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of MedicineDepartment of Biochemistry & Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of MedicineDepartment of Surgery, Yonsei University College of MedicineDepartment of Internal Medicine, Yonsei University College of MedicineDepartment of Molecular Medicine and Biopharmaceutical Sciences, School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National UniversityDepartment of Physiology, Keimyung University School of MedicineDepartment of Pathology, Keimyung University School of MedicineDepartment of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of MedicineLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of HealthDepartment of Biochemistry & Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of MedicineAbstract Nonalcoholic fatty liver disease (NAFLD) occurs due to the accumulation of fat in the liver, leading to fatal liver diseases such as nonalcoholic steatohepatitis (NASH) and cirrhosis. Elucidation of the molecular mechanisms underlying NAFLD is critical for its prevention and therapy. Here, we observed that deubiquitinase USP15 expression was upregulated in the livers of mice fed a high-fat diet (HFD) and liver biopsies of patients with NAFLD or NASH. USP15 interacts with lipid-accumulating proteins such as FABPs and perilipins to reduce ubiquitination and increase their protein stability. Furthermore, the severity of NAFLD induced by an HFD and NASH induced by a fructose/palmitate/cholesterol/trans-fat (FPC) diet was significantly ameliorated in hepatocyte-specific USP15 knockout mice. Thus, our findings reveal an unrecognized function of USP15 in the lipid accumulation of livers, which exacerbates NAFLD to NASH by overriding nutrients and inducing inflammation. Therefore, targeting USP15 can be used in the prevention and treatment of NAFLD and NASH.https://doi.org/10.1038/s12276-023-01036-7
spellingShingle Jung-Hwan Baek
Myung Sup Kim
Hye Ryeon Jung
Min-Seon Hwang
Chan-ho Lee
Dai Hoon Han
Yong-ho Lee
Eugene C. Yi
Seung-Soon Im
Ilseon Hwang
Kyungeun Kim
Joon-Yong Chung
Kyung-Hee Chun
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Experimental and Molecular Medicine
title Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
title_full Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
title_fullStr Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
title_full_unstemmed Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
title_short Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
title_sort ablation of the deubiquitinase usp15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
url https://doi.org/10.1038/s12276-023-01036-7
work_keys_str_mv AT junghwanbaek ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT myungsupkim ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT hyeryeonjung ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT minseonhwang ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT chanholee ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT daihoonhan ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT yongholee ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT eugenecyi ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT seungsoonim ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT ilseonhwang ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT kyungeunkim ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT joonyongchung ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis
AT kyungheechun ablationofthedeubiquitinaseusp15amelioratesnonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis